Kocher‑DiGeorge Syndrome – Comprehensive Medical Guide

Overview

Kocher‑DiGeorge syndrome (KDGS), also called 22q11.2 deletion syndrome, velocardiofacial syndrome, or conotruncal anomaly face syndrome, is a genetic disorder caused by the deletion of a small piece of chromosome 22. The missing genetic material affects the development of many body systems, leading to a wide spectrum of physical, neurocognitive, and psychiatric features.

• Who it affects: Both males and females of any ethnicity. Because it is a chromosomal deletion, it can be inherited from an affected parent (about 10–15 % of cases) or arise spontaneously (≈85 %).
• Prevalence: Occurs in roughly 1 in 4,000 – 1 in 6,000 live births, making it one of the most common microdeletion syndromes worldwide (Mayo Clinic; CDC).
• Age of presentation: Many signs appear in infancy (e.g., heart defects, feeding difficulties), but the full phenotype may not be recognized until childhood or even adulthood.

Symptoms

Because the deleted region contains many genes, the clinical picture is highly variable. Below is a comprehensive list, grouped by organ system.

Cardiovascular

• Conotruncal heart defects: Tetralogy of Fallot, truncus arteriosus, interrupted aortic arch, and ventricular septal defects (VSDs) are most common (≈70 % of patients).
• Peripheral vascular anomalies: Abnormalities of the aortic arch or pulmonary vessels.

Facial & Craniofacial

• Small, low-set ears; hooded eyelids; elongated face; thin upper lip.
• High‑arched palate or cleft palate (≈15 %).
• Dental problems: delayed eruption, enamel hypoplasia, crowding.

Immune System

• Thymic hypoplasia or aplasia → mild to severe T‑cell deficiency.
• Recurrent sinopulmonary infections, especially in early childhood.
• Increased risk for autoimmune disorders (e.g., autoimmune thyroid disease, celiac disease).

Endocrine

• Hypoparathyroidism → low calcium, tetany, seizures (especially in the newborn period).
• Growth hormone deficiency.
• Thyroid dysfunction (hypothyroidism or, rarely, hyperthyroidism).

Gastrointestinal & Feeding

• Feeding difficulties, poor weight gain, gastroesophageal reflux.
• Structural anomalies such as duodenal atresia or intestinal malrotation (less common).

Neurologic & Developmental

• Developmental delay (speech often most affected).
• Learning disabilities; average IQ ranges from 70–85, but there is a wide distribution.
• Motor coordination problems (dyspraxia).
• Seizures (≈5‑10 %).

Psychiatric

• Elevated risk of anxiety disorders, ADHD, and autism spectrum disorder.
• Adolescents and adults have a 20‑30 % lifetime risk of schizophrenia or related psychosis (NIH).

Other Features

• Hearing loss (conductive or sensorineural).
• Kidney anomalies (e.g., renal agenesis, cystic dysplasia).
• Musculoskeletal: scoliosis, chest wall deformities.

Causes and Risk Factors

KDGS is caused by a hemizygous deletion on chromosome 22q11.2 that removes about 30‑50 genes, the most critical being TBX1. The deletion size can vary, but the typical “typical 3‑Mb deletion” accounts for ~90 % of cases.

How the deletion occurs

• De novo mutation: Most cases arise spontaneously during the formation of egg or sperm (≈85 %).
• Inherited deletion: An affected parent passes the deletion to a child (≈10‑15 %).

Risk factors

• Having an affected parent or sibling (autosomal dominant inheritance).
• Advanced parental age modestly increases the chance of de novo deletions.
• No known environmental triggers; the deletion is a random chromosomal event.

Diagnosis

Early recognition is essential because many complications are preventable with timely treatment.

Clinical suspicion

• Presence of a conotruncal heart defect + facial dysmorphism.
• Combination of hypocalcemia, immune deficiency, and developmental delay.
• Family history of 22q11.2 deletion.

Genetic testing

• Fluorescence in‑situ hybridization (FISH): Detects the classic 3‑Mb deletion; still used in many centers.
• Chromosomal microarray (CMA): High‑resolution, detects typical and atypical deletions; now the first‑line test (American College of Medical Genetics).
• MLPA (Multiplex Ligation‑dependent Probe Amplification): Useful for confirming deletions and identifying small atypical changes.

Additional evaluations

• Cardiology: Echocardiogram, ECG, and cardiac MRI as indicated.
• Immunology: T‑cell counts, vaccine response testing.
• Endocrinology: Serum calcium, parathyroid hormone, thyroid panel, growth hormone assessment.
• Audiology & Speech‑language assessment.
• Renal ultrasound to screen for kidney anomalies.
• Neuropsychological testing for baseline cognition and learning needs.

Treatment Options

There is no cure; management is multidisciplinary, targeting each organ system.

Cardiac care

• Surgical repair of Tetralogy of Fallot, VSD, truncus arteriosus, or aortic arch anomalies (often within the first year of life).
• Regular cardiology follow‑up for residual lesions, arrhythmias, or pulmonary hypertension.

Calcium & Parathyroid management

• Acute hypocalcemia: Intravenous calcium gluconate, followed by oral calcium carbonate or citrate.
• Long‑term: Calcium supplements, active vitamin D analogs (calcitriol), and periodic serum calcium monitoring.

Immune support

• For mild T‑cell deficiency: Routine immunizations (except live vaccines if count < 200 cells/µL).
• Severe deficiency: Consider prophylactic antibiotics, immunoglobulin replacement, or hematopoietic stem‑cell transplantation in rare cases.

Endocrine & Growth

• Thyroid hormone replacement for hypothyroidism.
• Growth hormone therapy after pediatric endocrinology evaluation when indicated.

Speech, feeding, and developmental therapies

• Early intervention services: occupational therapy, speech‑language pathology, and physical therapy.
• Feeding specialists for GERD or dysphagia; sometimes gastrostomy tube placement.
• Special education plans (IEP) tailored to cognitive profile.

Psychiatric & behavioral care

• Behavioral therapy for ADHD, anxiety, or autism traits.
• Antipsychotic medication and psychotherapy for psychosis (when it emerges).
• Family counseling and support groups.

Social & lifestyle interventions

• Vaccination schedule per CDC recommendations (avoid live vaccines if severe T‑cell deficiency).
• Regular dental care to prevent caries associated with enamel defects.
• Sun protection & skin monitoring if on long‑term immunosuppression.

Living with Kocher‑DiGeorge Syndrome

While KDGS presents challenges, many individuals lead productive lives with appropriate support.

Practical daily‑management tips

1. Medication schedule: Use a pill organizer or smartphone reminders for calcium, vitamin D, thyroid hormone, and any psychotropic meds.
2. Routine labs: Keep a log of calcium, thyroid, and immune panels; schedule them every 6‑12 months or as directed.
3. School advocacy: Provide the school with a written medical summary; request accommodations such as extra test time, speech‑language support, and a 504 plan.
4. Nutrition: Ensure adequate calcium‑rich foods (dairy, fortified alternatives, leafy greens). If feeding difficulties persist, work with a dietitian.
5. Safety: Immediate treatment of low‑calcium symptoms (tingling, muscle cramps) with oral calcium; carry emergency calcium tablets if prescribed.
6. Vaccination: Keep an up‑to‑date immunization record; discuss live‑vaccine eligibility with immunology.
7. Psychosocial health: Join patient‑parent support groups (e.g., DiGeorge Foundation) to share strategies and reduce isolation.

Transition to adult care

At ages 16‑21, coordinate a transition plan with pediatric specialists to ensure continuity of cardiac, endocrine, psychiatric, and genetic follow‑up.

Prevention

Because KDGS results from a chromosomal deletion, primary prevention is limited.

• Genetic counseling: Couples with an affected family member should meet a genetic counselor to discuss recurrence risk and options such as preimplantation genetic diagnosis (PGD) or prenatal testing (chorionic villus sampling, amniocentesis).
• Pregnancy care: No evidence links maternal lifestyle or exposures to the 22q11.2 deletion, but standard prenatal care (folic acid, avoidance of teratogens) remains important for overall fetal health.

Complications

If any system is left untreated, complications can be severe.

• Cardiac: Heart failure, arrhythmias, endocarditis.
• Hypocalcemia: Tetany, seizures, prolonged QT interval → sudden cardiac death.
• Immune deficiency: Chronic lung infections, opportunistic infections, increased malignancy risk.
• Neuropsychiatric: Unmanaged psychosis, severe anxiety, or depression leading to self‑harm.
• Renal: Progressive renal insufficiency from congenital anomalies.
• Growth & bone health: Osteopenia/osteoporosis due to chronic calcium/vitamin D imbalance.

When to Seek Emergency Care

References

• Mayo Clinic. “22q11.2 deletion syndrome.” Accessed June 2026.
• Centers for Disease Control and Prevention. “Genetic Disorders: 22q11.2 Deletion Syndrome.” 2024.
• National Institutes of Health – National Heart, Lung, and Blood Institute. “Congenital Heart Defects in 22q11.2 Deletion Syndrome.” 2023.
• World Health Organization. “Guidelines for the Management of Rare Genetic Disorders.” 2022.
• Cleveland Clinic. “Hypoparathyroidism and Calcium Management.” 2024.
• American College of Medical Genetics and Genomics. “Practice guideline for diagnostic testing for 22q11.2 deletion syndrome.” 2022.